<?xml version="1.0" encoding="UTF-8"?>
<ref id="pntd.0007547.ref062">
 <label>62</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Eldi</surname>
   <given-names>P</given-names>
  </name>, 
  <name>
   <surname>Cooper</surname>
   <given-names>TH</given-names>
  </name>, 
  <name>
   <surname>Liu</surname>
   <given-names>L</given-names>
  </name>, 
  <name>
   <surname>Prow</surname>
   <given-names>NA</given-names>
  </name>, 
  <name>
   <surname>Diener</surname>
   <given-names>KR</given-names>
  </name>, 
  <name>
   <surname>Howley</surname>
   <given-names>PM</given-names>
  </name>, 
  <name>
   <surname>Suhrbier</surname>
   <given-names>A</given-names>
  </name>, 
  <name>
   <surname>Hayball</surname>
   <given-names>JD</given-names>
  </name> (
  <year>2017</year>) 
  <article-title>Production of a Chikungunya Vaccine Using a CHO Cell and Attenuated Viral-Based Platform Technology</article-title>. 
  <source>Mol Ther</source>
  <volume>25</volume>: 
  <fpage>2332</fpage>â€“
  <lpage>2344</lpage>. S1525-0016(17)30280-0 [pii]; 
  <pub-id pub-id-type="doi">10.1016/j.ymthe.2017.06.017</pub-id>
  <?supplied-pmid 28720468?>
  <pub-id pub-id-type="pmid">28720468</pub-id>
 </mixed-citation>
</ref>
